Drugs Administered Other than Oral Method sees Medicaid spending reach $1,143 in Kilmichael for 2024

In 2024, Medicaid providers in Kilmichael submitted $1,143 in claims for Drugs Administered Other than Oral Method services, according to information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This amount reflects a 517.8% rise from 2023, when claims under that service category totaled $185.

Medicaid is a government health plan administered by each state and co-funded by federal and state governments. It provides coverage for low-income groups, older adults, children and those with disabilities, making it one of the largest health systems in the nation.

Because Medicaid funding comes from public sources, shifts in what gets billed locally illustrate how public health care funding is directed within each community.

The “Drugs Administered Other than Oral Method” group includes a range of Medicaid services identified by the type of care delivered, as determined through standard HCPCS and CPT code sets. For this report, service codes were grouped into a single category based on tags and number sequences to ensure similar procedures could be compared and ranked each year, while avoiding duplicate counts.

Despite increased spending across several service types, Drugs Administered Other than Oral Method was the second-largest Medicaid payment group in Kilmichael for 2024.

Statewide, Mississippi ranked this category 14th by total Medicaid payments during 2024.

From 2019 through 2024, Medicaid payments related to the Drugs Administered Other than Oral Method group in Kilmichael rose by $2,364, or 67.4%. Certain years saw accelerated growth, including significant year-on-year gains in 2020 and 2022.

Although spending for Drugs Administered Other than Oral Method was present across Kilmichael, the majority of payments came from just a few ZIP codes. In 2024, the 39747 ZIP code accounted for $1,143, representing 100% of Medicaid payments in this service category for the city.

Within the Drugs Administered Other than Oral Method group, spending was focused on a small set of Medicaid billing codes.

To provide context, Medicaid payments for this category in Kilmichael grew by 517.8% between 2023 and 2024, in contrast with a 41.3% rise across all Medicaid service categories in the city during this time.

According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid expenditures reached about $871.7 billion for fiscal 2023, making up around 18% of all U.S. health spending, up sharply from about $613.5 billion in 2019, prior to the COVID-19 pandemic.

This increase is a growth of nearly 40% in just a few years, primarily fueled by wider enrollment and greater service use during and after the pandemic.

Recent federal budget measures under the Trump administration have included major proposals aimed at shrinking federal Medicaid funding and revising the program’s structure. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid outlays by more than $1 trillion over 10 years and implement requirements such as work documentation and higher cost-sharing, which may result in less coverage and funding for certain recipients. These changes are likely to transfer more costs to states and restrict growth in federal Medicaid funds, even as the program remains essential for millions of Americans.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.